Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Wooltorton

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 8, 2003
Accutane (isotretinoin) and psychiatric adverse effectsEric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 31, 2002
Brief safety updates: acetaminophen, ASA and kavaEric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 13, 2002
Mefloquine: contraindicated in patients with mood, psychotic or seizure disordersEric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 26, 2002
Ototoxic effects from gentamicin ear dropsEric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 3, 2002
Cochlear implant recipients at risk for meningitisEric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 20, 2002
What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex)Eric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 4, 2005
Medroxyprogesterone acetate (Depo-Provera) and bone mineral density lossEric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 3, 2005
Patients receiving intravenous bisphosphonates should avoid invasive dental proceduresEric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 15, 2006
Medications for attention deficit hyperactivity disorder: cardiovascular concernsEric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 29, 2003
Concerns over lindane treatment for scabies and liceEric Wooltorton
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 8, 2003
Accutane (isotretinoin) and psychiatric adverse effectsEric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 31, 2002
Brief safety updates: acetaminophen, ASA and kavaEric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 13, 2002
Mefloquine: contraindicated in patients with mood, psychotic or seizure disordersEric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 26, 2002
Ototoxic effects from gentamicin ear dropsEric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 3, 2002
Cochlear implant recipients at risk for meningitisEric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 20, 2002
What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex)Eric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 4, 2005
Medroxyprogesterone acetate (Depo-Provera) and bone mineral density lossEric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 3, 2005
Patients receiving intravenous bisphosphonates should avoid invasive dental proceduresEric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 15, 2006
Medications for attention deficit hyperactivity disorder: cardiovascular concernsEric Wooltorton
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 29, 2003
Concerns over lindane treatment for scabies and liceEric Wooltorton
Pageof 8